title: Polymerization of three hemoglobin A2 variants containing Val6 and inhibition of hemoglobin S polymerization by hemoglobin A2.
abstract: To understand determinants for hemoglobin (Hb) stability and Hb A2 inhibition of Hb S polymerization, three Valdelta6 Hb A2 variants (Hb A2 deltaE6V, Hb A2 deltaE6V,deltaQ87T, and Hb A2 deltaE6V, deltaA22E,deltaQ87T) were expressed in yeast, and stability to mechanical agitation and polymerization properties were assessed. Oxy forms of Hb A2 deltaE6V and Hb A2 deltaE6V,deltaQ87T were 2- and 1.6-fold, respectively, less stable than oxy-Hb S, while the stability of Hb A2 deltaE6V,deltaA22E,deltaQ87T was similar to that of Hb S, suggesting that Aladelta22 and Glndelta87 contribute to the surface hydrophobicity of Hb A2. Deoxy Hb A2 deltaE6V polymerized without a delay time, like deoxy Hb F gammaE6V, while deoxy Hb A2 deltaE6V,deltaQ87T and deoxy Hb A2 deltaE6V,deltaA22E,deltaQ87T polymerized after a delay time, like deoxy Hb S, suggesting that beta87 Thr is required for the formation of nuclei. Deoxy Hb F gammaE6V,gammaQ87T showed no delay time and required a 3.5-fold higher concentration than deoxy Hb S for polymerization, suggesting that Thr effects on Valdelta6 Hb A2 and Valgamma6 Hb F variants are different. Mixtures of deoxy Hb S/Hb A2 deltaE6V,deltaQ87T polymerized, like deoxy Hb S, while polymerization of Hb S/Hb A2 deltaE6V mixtures was inhibited, like Hb S/Hb F gammaE6V mixtures. These results suggest alpha2betaSdelta6 Val, 87 Thr hybrids and Hb A2 deltaE6V,deltaQ87T participate in Hb S nucleation, while only 50% of alpha2betaSdelta6 Val hybrids and none of the Hb A2 deltaE6V participate. These findings are in contrast to those of mixtures of Hb S with Hb F gammaE6V or Hb F gammaE6V,Q87T, which both inhibit Hb S polymerization. Our results also suggest participation in nucleation of some alpha2betaSdelta hybrids in A2S mixtures but not alpha2betaSgamma hybrids in FS mixtures.
authors.affiliation: Children's Hospital of Philadelphia, Division of Hematology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
authors.forename: K
authors.initials: K
authors.lastname: Adachi
authors.forename: J
authors.initials: J
authors.lastname: Pang
authors.forename: L R
authors.initials: LR
authors.lastname: Reddy
authors.forename: L E
authors.initials: LE
authors.lastname: Bradley
authors.forename: Q
authors.initials: Q
authors.lastname: Chen
authors.forename: P
authors.initials: P
authors.lastname: Trifillis
authors.forename: E
authors.initials: E
authors.lastname: Schwartz
authors.forename: S
authors.initials: S
authors.lastname: Surrey
mesh_terms: D000818:Animals; D001704:Biopolymers; D019556:COS Cells; D002853:Chromatography, Liquid; D004588:Electrophoresis, Cellulose Acetate; D006443:Hemoglobin A2 / Q000737:chemistry* / Q000378:metabolism; D006451:Hemoglobin, Sickle / Q000037:antagonists & inhibitors* / Q000737:chemistry; D006801:Humans; D014633:Valine / Q000032:analysis*
chemical_list: D001704:Biopolymers; D006451:Hemoglobin, Sickle; D006443:Hemoglobin A2; D014633:Valine